Latest
Crucial Metrics to Monitor for Intuitive Surgical and a Valuation Analysis
Ascendis Pharma (ASND): Redefining Drug Delivery with TransCon
Halozyme Therapeutics (HALO): Bets on Licensing Model to Drive Growth
GLP-1 Drugs: Not a Miracle Cure for Weight Loss
Intuitive Surgical (ISRG) Deep Dive
An Overview of CAR-T Cell Therapy And a New Manufacturing Method
Technologies in 5 mins
From Blueprint to Therapy: The Evolution and Challenges of Nucleic Acid Interventions
An Overview of CAR-T Cell Therapy And a New Manufacturing Method
The race to sequence the world - A look at Next Generation Sequencing (NGS)
All you need to know about Gene Therapy
Exploring Drug Modalities: Small Molecules, Biologics, RNA, Cell & Gene Therapy
Can Precision Fermentation together with Synthetic Biology Help to Secure Our Food Systems?
An Overview of RNA Technologies
Deep Dives
Crucial Metrics to Monitor for Intuitive Surgical and a Valuation Analysis
A few months ago, we conducted an in-depth analysis of Intuitive Surgical (ISRG) and performed a preliminary valuation. In our most recent research, we dedicated time to a more comprehensive examination of Intuitive Surgical's growth prospects and financials. Our goal was to identify the essential factors that shape
Ascendis Pharma (ASND): Redefining Drug Delivery with TransCon
Halozyme Therapeutics (HALO): Bets on Licensing Model to Drive Growth
Intuitive Surgical (ISRG) Deep Dive
Danaher Corporation (DHR) Valuation Exercise
Novo Nordisk (NVO) Deep Dive
Thermo Fisher Scientific (TMO) Deep Dive
News
Are RSV vaccines going to be the next blockbuster vaccine to be developed?
The below graph shows that the rate of RSV-associated hospitalizations has increased significantly after the COVID pandemic (2020-2021 season).
In the 2022-2023 season, the current estimate for RSV-associated hospitalization stood at 18 per 100k people in the US. However, this is just the start of the RSV season, and the
3 Top Biotech News Of The Week (22 Oct 2022) - Oculis, LLY, AKUS, JAZZ, ZYME
A look at Nimbus & Eli Lilly's AMPK Collaboration, Regeneron and Sanofi's Dupixent EOE approval and Merck's Sotatercept for PAH
3 Top Biotech News Of The Week (8 October 22) - BMS, AUTL, DNA, Svante Pääbo discovery
3 Top Biotech News Of The Week (1 October 22)
3 Top Biotech News Of The Week (10 September 22)
